Ironwood Pharmaceuticals | IRWD - 销售毛利



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.24
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 732.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 106.51M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


销售毛利 更改 日
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Almirall EUR 429.87M 180.02M 2025-12
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Amarin USD 23.17M 961K 2025-12
Ardelyx USD 89.66M 24.7M 2026-03
Astellas Pharma JPY 444.26B 12.55B 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Coherus Biosciences USD 8.7M 853K 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Incyte USD 1.17B 217.51M 2026-03
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
MacroGenics USD 11.24M 19.87M 2026-03
Moderna USD -566M 792M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 126.64M 15.61M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Takeda JPY 688.84B 101.71B 2026-03
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12